These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9800121)

  • 1. Retinoids in the chemoprevention of bladder cancer.
    Sabichi AL; Lerner SP; Grossman HB; Lippman SM
    Curr Opin Oncol; 1998 Sep; 10(5):479-84. PubMed ID: 9800121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group.
    Kurth KH; Bouffioux C; Sylvester R; van der Meijden AP; Oosterlinck W; Brausi M
    Eur Urol; 2000; 37 Suppl 3():1-9. PubMed ID: 10828681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks and benefits of retinoids in the chemoprevention of cancer.
    de Palo G; Formelli F
    Drug Saf; 1995 Oct; 13(4):245-56. PubMed ID: 8573297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin A and Retinoids in Bladder Cancer Chemoprevention and Treatment: A Narrative Review of Current Evidence, Challenges and Future Prospects.
    Tratnjek L; Jeruc J; Romih R; Zupančič D
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoids in cancer chemoprevention. Clinical trials with the synthetic analogue fenretinide.
    Costa A; De Palo G; Decensi A; Formelli F; Chiesa F; Nava M; Camerini T; Marubini E; Veronesi U
    Ann N Y Acad Sci; 1995 Sep; 768():148-62. PubMed ID: 8526344
    [No Abstract]   [Full Text] [Related]  

  • 6. Retinoids and chemoprevention: clinical and basic studies.
    Lippman SM; Heyman RA; Kurie JM; Benner SE; Hong WK
    J Cell Biochem Suppl; 1995; 22():1-10. PubMed ID: 8538183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of carcinogenesis in the urinary bladder by retinoids.
    Hicks RM; Turton JA; Chowaniec J; Tomlinson CN; Gwynne J; Nandra K; Chrysostomou E; Pedrick M
    Ciba Found Symp; 1985; 113():168-90. PubMed ID: 3849405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of fenretinide-induced modulation of circulating insulin-like growth factor (IGF)-i, IGF-II and IGFBP-3 in a bladder cancer chemoprevention trial.
    Torrisi R; Mezzetti M; Johansson H; Barreca A; Pigatto F; Robertson C; Decensi A
    Int J Cancer; 2000 Aug; 87(4):601-5. PubMed ID: 10918204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoids in the prevention of bladder cancer.
    Nutting CM; Huddart RA
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):541-5. PubMed ID: 12113086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classical and novel retinoids: their targets in cancer therapy.
    Fontana JA; Rishi AK
    Leukemia; 2002 Apr; 16(4):463-72. PubMed ID: 11960323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic.
    Ki Hong W; Lippman SM; Hittelman WN; Lotan R
    Clin Cancer Res; 1995 Jul; 1(7):677-86. PubMed ID: 9816032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoids in bladder, testis and prostate cancer: epidemiologic, pre-clinical and clinical observations.
    Trump DL
    Leukemia; 1994; 8 Suppl 3():S50-4. PubMed ID: 7808025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoids in chemoprevention of head and neck carcinogenesis.
    Lippman SM; Benner SE; Hong WK
    Prev Med; 1993 Sep; 22(5):693-700. PubMed ID: 8234209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells.
    Zou C; Liebert M; Zou C; Grossman HB; Lotan R
    J Urol; 2001 Mar; 165(3):986-92. PubMed ID: 11176527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of chemopreventive agent N-(4-hydroxyphenyl) retinamide (4-HPR) and gamma-radiation on bladder cancer cell lines.
    Zou C; Wang L; Liebert M; Grossman HB; Lotan R; Wei Q
    Int J Oncol; 1998 Nov; 13(5):1037-41. PubMed ID: 9772297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The retinoids and cancer prevention mechanisms.
    Dragnev KH; Rigas JR; Dmitrovsky E
    Oncologist; 2000; 5(5):361-8. PubMed ID: 11040271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells.
    Zou C; Zhou J; Qian L; Feugang JM; Liu J; Wang X; Wu S; Ding H; Zou C; Liebert M; Grossman HB
    Front Biosci; 2006 Sep; 11():2007-16. PubMed ID: 16720286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis.
    Lippman SM; Benner SE; Hong WK
    Cancer Res; 1994 Apr; 54(7 Suppl):2025s-2028s. PubMed ID: 8137332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic retinoid fenretinide in breast cancer chemoprevention.
    Bonanni B; Lazzeroni M; Veronesi U
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):423-32. PubMed ID: 17428163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of chemopreventive agents for bladder cancer.
    Kelloff GJ; Boone CW; Malone WF; Steele VE; Doody LA
    J Cell Biochem Suppl; 1992; 16I():1-12. PubMed ID: 1305671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.